Biogen (BIIB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Biogen (NASDAQ:BIIB) shares experienced a change in market expectations as Cantor Fitzgerald revised the company's price target. The new target has been set at $206.00, a decrease from the previous ...

Of the 102 company launches or series A financings since October 2023, just nine had a woman at the helm, according to a ...

Everyone is encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1 ...

The Payment Card Industry Data Security Standard’s 4.0 requirements are designed to protect card information from theft or ...

The Washington University trial comes as part of a larger platform study which hopes to understand if Alzheimer's disease can ...

Request To Download Free Sample of This Strategic Report @ Highlighted with 36 tables and 83 figures, this 153-page report ?North America Biopharmaceuticals Market 2023-2033 by Product Type, Testing ...

Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., Appeal Nos. 2024-1965, -1966, -2082, -2083 (Fed. Cir. Jan. 29, 2025) ...

As the nation kicks off Black History Month, a look into the industry shows there is a significant lack of Black leaders.

An additional rituximab dose in patients with pemphigus and at least one predictor of relapse may reduce the relapse rate, according to the results of a multicenter French study.

Market uncertainty makes investors nervous about investing in speculative industries. But Wall Street has high hopes for ...

David Rubenstein, Co-Founder and Co-Chairman of The Carlyle Group; Ken Griffin, Founder and CEO of Citadel; Penny Pritzker, former U.S. Commerce Secretary; and Henry Kravis, ...